Pediatric Primary Cutaneous Lymphoma in China: A Retrospective Study

Background: The incidence and clinical features of primary cutaneous lymphoma (PCL) tend to differ by age, gender, geographical, and racial variation. All-aged and adult groups of PCL in various regions have been well demonstrated and compared, while the research concentrating on pediatric PCL is rare, especially in Asian countries. Objective: The aim of this study was to investigate the clinical characteristics of PCL in pediatric population at a single center in China. Methods: We conducted a retrospective study of 101 pediatric cases with PCL, diagnosed at the Institute of Dermatology, Chinese Academy of Medical Sciences, from January 2010 to December 2021. Results: Mycosis fungoides (MF), accounting for 41.6% of the total cases, was the most common subtype in pediatric PCL, and the hypopigmented MF accounted for 47.6% of all the MF cases. Lymphomatoid papulosis and chronic active Epstein-Barr virus infection tied for second place with a proportion of 22.8%. Primary cutaneous anaplastic large cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma, primary cutaneous peripheral T-cell lymphoma, rare subtypes and primary cutaneous B-cell lymphoma, respectively, accounted for 2.0%, 4.0%, 4.0%, and 3.0%. Most patients had favorable prognosis during the follow-up. Conclusion: The study suggested that MF was the most common subtype in pediatric PCL in China, and most types of pediatric PCL had favorable prognosis.

[1]  C. Magro,et al.  Lymphomatoid papulosis in children and adolescents: A clinical and histopathologic retrospective cohort. , 2020, Annals of diagnostic pathology.

[2]  E. Jaffe,et al.  Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting , 2019, Leukemia & lymphoma.

[3]  Joanne R. Winter,et al.  Predictors of Epstein-Barr virus serostatus in young people in England , 2019, BMC Infectious Diseases.

[4]  Y. Liu,et al.  Clinical characteristics of primary cutaneous lymphoma: analysis from two centres in China , 2019, The British journal of dermatology.

[5]  E. Jaffe,et al.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. , 2019, Blood.

[6]  A. Arai Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development , 2019, Front. Pediatr..

[7]  Zhengde Xie,et al.  Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland , 2018, Front. Pediatr..

[8]  M. Rovaris,et al.  Pediatric CD8+/CD56+ mycosis fungoides with cytotoxic marker expression: A variant with indolent course , 2018, Journal of cutaneous pathology.

[9]  J. Cohen,et al.  Chronic Active Epstein–Barr Virus Disease , 2017, Front. Immunol..

[10]  H. Tagawa,et al.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features , 2017, Haematologica.

[11]  J. Guitart,et al.  CD8+ mycosis fungoides: A low‐grade lymphoproliferative disorder , 2017, Journal of the American Academy of Dermatology.

[12]  R. Halder,et al.  Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  E. Pope,et al.  Primary Cutaneous Lymphomas in Children and Adolescents , 2016, Pediatric blood & cancer.

[14]  Hanspaul S. Makkar,et al.  Cutaneous lymphoma: Kids are not just little people. , 2016, Clinics in dermatology.

[15]  Hyun Soo Lee,et al.  Cutaneous Lymphoma in Korea: A Nationwide Retrospective Study. , 2016, Acta dermato-venereologica.

[16]  M. Duvic,et al.  Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review , 2016, American Journal of Clinical Dermatology.

[17]  M. Link,et al.  Subcutaneous panniculitis‐like T‐cell lymphoma: Pediatric case series demonstrating heterogeneous presentation and option for watchful waiting , 2015, Pediatric blood & cancer.

[18]  G. Yoon,et al.  Congenital primary cutaneous anaplastic large-cell lymphoma: a case report. , 2015, The American Journal of dermatopathology.

[19]  S. Chang,et al.  Paediatric cutaneous lymphoma in Korea: a retrospective study at a single institution , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  D. Ivan,et al.  Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients. , 2014, Journal of the American Academy of Dermatology.

[21]  N. Shear,et al.  Childhood Mycosis Fungoides: Experience of 28 Patients and Response to Phototherapy , 2014, Pediatric dermatology.

[22]  E. Chang,et al.  Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study. , 2014, JAMA dermatology.

[23]  H. Kutzner,et al.  Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings. , 2013, Journal of the American Academy of Dermatology.

[24]  C. Baykal,et al.  Childhood mycosis fungoides: a report of 20 cases from Turkey , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[25]  T. Mentzel,et al.  Angioinvasive Lymphomatoid Papulosis: A New Variant Simulating Aggressive Lymphomas , 2013, The American journal of surgical pathology.

[26]  Y. Ko,et al.  World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution. , 2012, Journal of the American Academy of Dermatology.

[27]  T. Naoe,et al.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. , 2012, Blood.

[28]  K. Iwatsuki,et al.  Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008 , 2011, The Journal of dermatology.

[29]  Y. Kashii,et al.  Six‐year‐old girl with primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[30]  L. French,et al.  Primary cutaneous lymphoma: two‐decade comparison in a population of 263 cases from a Swiss tertiary referral centre , 2011, The British journal of dermatology.

[31]  M. Demierre,et al.  Mycosis Fungoides in Arab Children and Adolescents: A Report of 36 Patients from Kuwait , 2010, Pediatric dermatology.

[32]  Z. Argényi,et al.  A Variant of Lymphomatoid Papulosis Simulating Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma. Description of 9 Cases , 2010, The American journal of surgical pathology.

[33]  M. Camilleri,et al.  Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients. , 2009, Journal of the American Academy of Dermatology.

[34]  Y. Jeon,et al.  Clinicopathological features and T‐cell receptor gene rearrangement findings of mycosis fungoides in patients younger than age 20 years , 2009, The Journal of dermatology.

[35]  S. Devesa,et al.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. , 2009, Blood.

[36]  K. Ohshima,et al.  Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD , 2008, Pathology international.

[37]  M. Tang,et al.  Retrospective 5‐year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore , 2006, The Australasian journal of dermatology.

[38]  M. Kim,et al.  Nodal marginal zone lymphoma in association with hydroa vacciniforme‐like papulovesicular eruption, hypersensitivity to mosquito bites and insect bite‐like reaction , 2005, The British journal of dermatology.

[39]  H. Kerl,et al.  The Spectrum of Cutaneous Lymphomas in Patients Less than 20 Years of Age , 2004, Pediatric dermatology.

[40]  S. Whittaker,et al.  Outcome in 34 patients with juvenile‐onset mycosis fungoides , 2003, Cancer.

[41]  M. Lee Characteristics of cutaneous lymphomas in Korea , 2003, Clinical and experimental dermatology.

[42]  K. Yoshikawa,et al.  Characteristics of Cutaneous Lymphomas in Osaka, Japan (1988–1999) Based on the European Organization for Research and Treatment of Cancer Classification , 2000, The American Journal of dermatopathology.

[43]  T. McCalmont,et al.  Mycosis fungoides with onset before 20 years of age. , 1997, Journal of the American Academy of Dermatology.

[44]  B. Agnarsson,et al.  Peripheral T-cell lymphomas in children. , 1995, Seminars in diagnostic pathology.

[45]  P. Joly,et al.  Cutaneous lymphomas other than mycosis fungoides. , 1994, Seminars in dermatology.

[46]  P. Heerde,et al.  Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotype , 1993, Histopathology.

[47]  T. Chan,et al.  Primary and secondary cutaneous lymphomas in Hong Kong Chinese , 1990, Hematological oncology.

[48]  M. Weinstock,et al.  Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. , 1988, JAMA.

[49]  J. Burchenal,et al.  Non-Hodgkin's lymphoma in children. , 1976, Pediatric clinics of North America.

[50]  B. Cohen,et al.  Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management , 2019, Pediatric dermatology.

[51]  M. Feinmesser,et al.  Juvenile mycosis fungoides diagnosed before 18 years of age. , 2003, Acta dermato-venereologica.